sell depth dwindling, this slight pullback from 5.8 has been on miniscule volume. Sellers will all pull at once and we will finish very strongly All IMHO
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%